Legal Opinion
In re Orexigen Therapeutics, Inc.
United States Bankruptcy Court, D. Delaware
Decided November 13, 2018No. Case No. 18-10518 (KG)PublishedCited by 6 opinions
1Opinion of the Court
Re: D.I. 654
KEVIN GROSS, U.S.B.J.
The Court is ruling on McKesson Corporation's ("McKesson") and its wholly owned subsidiary McKesson Patient Relationship Solutions' ("MPRS") Motion for an Order Determining that McKesson is Entitled to the Disputed Funds (the "Motion")
*12(D.I. 654). McKesson seeks to affect a setoff under section 553 of the Bankruptcy Code.1 Specifically, McKesson asks to offset its $6,932,816.40 debt to the Debtor under the Core Distribution Agreement ("Distribution Agreement") based on the Debtor's approximately $9,100,0002 debt to MPRS under the Master Services Agreement…
2Cases cited38 opinions
- United States v. Ron Pair Enterprises, Inc.Supreme Court of the United States · 1989
- Butner v. United StatesSupreme Court of the United States · 1979
- Caminetti v. United StatesSupreme Court of the United States · 1917
- Marx v. General Revenue Corp.Supreme Court of the United States · 2013
- Citizens Bank of Md. v. StrumpfSupreme Court of the United States · 1995
33 more not listed; retrieve them via the Exa API.
3Cited by6 opinions
- Orexigen Therapeutics, Inc. v.Court of Appeals for the Third Circuit · 2021
- Andrew B ZezasUnited States Bankruptcy Court, D. New Jersey · 2023
- In Re: Windhaven Top Insurance Holdings, LLCDistrict Court, D. Delaware · 2023
- In re: Orexigen Therapeutics, Inc.District Court, D. Delaware · 2020
- In the Matter of the Rehabilitation of Scottish Re (U.S.), Inc.Court of Chancery of Delaware · 2020
1 more not listed; retrieve them via the Exa API.